BACKGROUND/AIMS: We report on deep brain stimulation (DBS) in the ventral intermediate part of the thalamus in 4 patients with complex tremor syndromes, 2 classified as Holmes tremor (HT) and 2 as thalamic tremor (TT). RESULTS: Three out of 4 patients showed intraoperative improvement and underwent DBS implantation. One patient with TT without intraoperative improvement was not provided with an implant. A sustained beneficial effect was present after a follow-up ranging from 20 months to 7 years, although there was partial persistence of the intentional tremor and of proximal myoclonic-dystonic movements. The mean global clinical impression score was 2. In 1 HT patient the benefit persisted after battery failure. CONCLUSION: The study confirms that ventral intermediate thalamic DBS can provide long-term efficacy for HT and TT. While the patients experienced considerable and lasting functional improvement, the effect was incomplete and not all elements of their complex movement disorders were equally suppressed. 2008 S. Karger AG, Basel.
BACKGROUND/AIMS: We report on deep brain stimulation (DBS) in the ventral intermediate part of the thalamus in 4 patients with complex tremor syndromes, 2 classified as Holmes tremor (HT) and 2 as thalamic tremor (TT). RESULTS: Three out of 4 patients showed intraoperative improvement and underwent DBS implantation. One patient with TT without intraoperative improvement was not provided with an implant. A sustained beneficial effect was present after a follow-up ranging from 20 months to 7 years, although there was partial persistence of the intentional tremor and of proximal myoclonic-dystonic movements. The mean global clinical impression score was 2. In 1 HTpatient the benefit persisted after battery failure. CONCLUSION: The study confirms that ventral intermediate thalamic DBS can provide long-term efficacy for HT and TT. While the patients experienced considerable and lasting functional improvement, the effect was incomplete and not all elements of their complex movement disorders were equally suppressed. 2008 S. Karger AG, Basel.
Authors: Jairo Alberto Espinoza Martinez; Gabriel J Arango; Erich Talamoni Fonoff; Thomas Reithmeier; Oscar Andrés Escobar; Luciano Furlanetti; G Rene Alvarez Berastegui; Fabio Eduardo Fernandes da Silva; William Omar Contreras Lopez Journal: Neurosurg Rev Date: 2015-05-20 Impact factor: 3.042
Authors: M Lefranc; M Manto; P Merle; M Tir; D Montpellier; J-M Constant; D Le Gars; J-M Macron; P Krystkowiak Journal: Cerebellum Date: 2014-06 Impact factor: 3.847
Authors: Carlo Alberto Artusi; Ashar Farooqi; Alberto Romagnolo; Luca Marsili; Roberta Balestrino; Leonard L Sokol; Lily L Wang; Maurizio Zibetti; Andrew P Duker; George T Mandybur; Leonardo Lopiano; Aristide Merola Journal: J Neurol Date: 2018-03-06 Impact factor: 4.849
Authors: Hans-Jochen Heinze; Marcus Heldmann; Jürgen Voges; Hermann Hinrichs; Josep Marco-Pallares; Jens-Max Hopf; Ulf J Müller; Imke Galazky; Volker Sturm; Bernard Bogerts; Thomas F Münte Journal: Front Hum Neurosci Date: 2009-09-02 Impact factor: 3.169
Authors: Thomas F Münte; Marcus Heldmann; Hermann Hinrichs; Josep Marco-Pallares; Ulrike M Krämer; Volker Sturm; Hans-Jochen Heinze Journal: Front Neurosci Date: 2008-07-07 Impact factor: 4.677